• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌手术和非手术患者的吸烟状况与长期生存结果:从不吸烟者和现吸烟者比较。

Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.

机构信息

Division of Thoracic Surgery, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

Chest. 2010 Sep;138(3):500-9. doi: 10.1378/chest.08-2991. Epub 2010 May 27.

DOI:10.1378/chest.08-2991
PMID:20507946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2940065/
Abstract

BACKGROUND

Survival outcomes of never smokers with non-small cell lung cancer (NSCLC) who undergo surgery are poorly characterized. This investigation compared surgical outcomes of never and current smokers with NSCLC.

METHODS

This investigation was a single-institution retrospective study of never and current smokers with NSCLC from 1975 to 2004. From an analytic cohort of 4,546 patients with NSCLC, we identified 724 never smokers and 3,822 current smokers. Overall, 1,142 patients underwent surgery with curative intent. For survival analysis by smoking status, hazard ratios (HRs) were estimated using Cox proportional hazard modeling and then further adjusted by other covariates.

RESULTS

Never smokers were significantly more likely than current smokers to be women (P < .01), older (P < .01), and to have adenocarcinoma (P < .01) and bronchioloalveolar carcinoma (P < .01). No statistically significant differences existed in stage distribution at presentation for the analytic cohort (P = .35) or for the subgroup undergoing surgery (P = .24). The strongest risk factors of mortality among patients with NSCLC who underwent surgery were advanced stage (adjusted hazard ratio, 3.43; 95% CI, 2.32-5.07; P < .01) and elevated American Society of Anesthesiologists classification (adjusted hazard ratio, 2.18; 95% CI, 1.40-3.40; P < .01). The minor trend toward an elevated risk of death on univariate analysis for current vs never smokers in the surgically treated group (hazard ratio, 1.20; 95% CI, 0.98-1.46; P = .07) was completely eliminated when the model was adjusted for covariates (P = .97).

CONCLUSIONS

Our findings suggest that smoking status at time of lung cancer diagnosis has little impact on the long-term survival of patients with NSCLC, especially after curative surgery. Despite different etiologies between lung cancer in never and current smokers the prognosis is equally dismal.

摘要

背景

从未吸烟的非小细胞肺癌 (NSCLC) 患者的手术生存结果特征不佳。本研究比较了从未吸烟和当前吸烟的 NSCLC 患者的手术结果。

方法

本研究是一项对 1975 年至 2004 年从未吸烟和当前吸烟的 NSCLC 患者的单机构回顾性研究。从 NSCLC 的分析队列 4546 例患者中,我们确定了 724 名从未吸烟者和 3822 名当前吸烟者。共有 1142 例患者接受了根治性手术。为了按吸烟状况进行生存分析,使用 Cox 比例风险模型估计风险比 (HR),然后进一步通过其他协变量进行调整。

结果

从未吸烟者明显比当前吸烟者更有可能是女性 (P <.01)、年龄更大 (P <.01)、腺癌 (P <.01) 和细支气管肺泡癌 (P <.01)。分析队列的分期分布 (P =.35) 或接受手术的亚组 (P =.24) 没有统计学上的显著差异。接受手术的 NSCLC 患者死亡的最强危险因素是晚期 (调整后的危险比,3.43;95%CI,2.32-5.07;P <.01) 和美国麻醉师协会分类升高 (调整后的危险比,2.18;95%CI,1.40-3.40;P <.01)。在手术治疗组中,当前吸烟者与从未吸烟者相比,死亡风险在单因素分析中略有增加 (危险比,1.20;95%CI,0.98-1.46;P =.07),但当模型调整协变量时,这一差异完全消除 (P =.97)。

结论

我们的发现表明,肺癌诊断时的吸烟状况对 NSCLC 患者的长期生存影响不大,尤其是在根治性手术后。尽管从未吸烟和当前吸烟的肺癌患者的病因不同,但预后同样不佳。

相似文献

1
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.非小细胞肺癌手术和非手术患者的吸烟状况与长期生存结果:从不吸烟者和现吸烟者比较。
Chest. 2010 Sep;138(3):500-9. doi: 10.1378/chest.08-2991. Epub 2010 May 27.
2
Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.基于人群的队列研究:吸烟史对非小细胞肺癌患者临床特征和生存的影响。
Acta Oncol. 2019 Nov;58(11):1618-1627. doi: 10.1080/0284186X.2019.1638521. Epub 2019 Aug 2.
3
Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.非小细胞肺癌手术后长期生存的性别差异
Thorac Cardiovasc Surg. 2016 Sep;64(6):507-14. doi: 10.1055/s-0035-1558995. Epub 2015 Sep 14.
4
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).非小细胞肺癌(NSCLC)终身不吸烟者的临床表现及特定分期结局。
J Thorac Oncol. 2007 Sep;2(9):827-30. doi: 10.1097/JTO.0b013e318145af79.
5
Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.体能状态和吸烟状态是非小细胞肺癌生存的独立有利预后因素:对 26957 例非小细胞肺癌患者的综合分析。
J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9.
6
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.吸烟状况与国家综合癌症网络非小细胞肺癌队列的生存情况。
Cancer. 2013 Feb 15;119(4):847-53. doi: 10.1002/cncr.27824. Epub 2012 Sep 28.
7
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.患非小细胞肺癌的吸烟者与从不吸烟者在流行病学、组织学和生存率方面的差异。
Chest. 2007 Jul;132(1):185-92. doi: 10.1378/chest.07-0442. Epub 2007 Jun 15.
8
Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.比较手术与立体定向体部放疗治疗早期非小细胞肺癌患者的长期生存情况。
JAMA Netw Open. 2019 Nov 1;2(11):e1915724. doi: 10.1001/jamanetworkopen.2019.15724.
9
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.一线免疫治疗和化疗期间非小细胞肺癌患者的吸烟状况:一项来自大型多中心研究的病例对照匹配分析。
Thorac Cancer. 2021 Mar;12(6):880-889. doi: 10.1111/1759-7714.13852. Epub 2021 Feb 1.
10
Smoking status and 30-day mortality in patients undergoing pulmonary resections.接受肺切除术患者的吸烟状况与30天死亡率
Asian Cardiovasc Thorac Ann. 2016 Sep;24(7):663-9. doi: 10.1177/0218492316657252. Epub 2016 Jun 30.

引用本文的文献

1
Clinical characteristics and prognosis of non-high-risk patients with incidental stage T1 lung cancer: A prospective cohort study.偶然发现的 T1 期非高危肺癌患者的临床特征和预后:一项前瞻性队列研究。
Clin Exp Med. 2024 Aug 21;24(1):195. doi: 10.1007/s10238-024-01459-0.
2
Conditional survival analysis of patients with resected non-small cell lung cancer.接受手术切除的非小细胞肺癌患者的条件生存分析
JTCVS Open. 2023 Sep 18;16:948-959. doi: 10.1016/j.xjon.2023.09.010. eCollection 2023 Dec.
3
Lung Cancer in Never Smokers: Delving into Epidemiology, Genomic and Immune Landscape, Prognosis, Treatment, and Screening.非吸烟人群中的肺癌:深入探究流行病学、基因组和免疫景观、预后、治疗和筛查。
Lung. 2023 Dec;201(6):521-529. doi: 10.1007/s00408-023-00661-3. Epub 2023 Nov 16.
4
Impact of Environmental Exposures on Lung Cancer in Patients Who Never Smoked.环境暴露对从不吸烟的肺癌患者的影响。
World J Surg. 2023 Oct;47(10):2578-2586. doi: 10.1007/s00268-023-07085-3. Epub 2023 Jul 4.
5
Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.中欧和东欧早期非小细胞肺癌的生存和预后因素:一项前瞻性队列研究。
Cancer Med. 2023 May;12(9):10563-10574. doi: 10.1002/cam4.5791. Epub 2023 Mar 23.
6
Risk Factors for the Diagnosis of Lung Cancer in Poland: A Large-Scale, Population-Based Case-Control Study.波兰肺癌诊断的风险因素:一项大规模、基于人群的病例对照研究。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3299-3307. doi: 10.31557/APJCP.2022.23.10.3299.
7
Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.体细胞突变结合临床特征可预测IIIA期肺腺癌的术后预后。
Ann Transl Med. 2022 Feb;10(4):187. doi: 10.21037/atm-22-130.
8
Long term follow-up of EGFR mutated NSCLC cases.表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)病例的长期随访
Transl Oncol. 2021 Jan;14(1):100934. doi: 10.1016/j.tranon.2020.100934. Epub 2020 Nov 10.
9
Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.Krüppel 样因子 6 剪接变异体 1(KLF6-SV1)过表达通过上调 TWIST1 招募巨噬细胞参与肺癌转移。
Cancer Biol Ther. 2019;20(5):680-691. doi: 10.1080/15384047.2018.1550570. Epub 2018 Dec 27.
10
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?非小细胞肺癌中的性别与预后:一个古老的预后变量在靶向治疗和免疫治疗中再度出现?
ESMO Open. 2018 Apr 13;3(3):e000344. doi: 10.1136/esmoopen-2018-000344. eCollection 2018.

本文引用的文献

1
Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study.肺癌切除术前戒烟的影响:一项胸外科医师协会普通胸外科数据库研究
Ann Thorac Surg. 2009 Aug;88(2):362-70; discussion 370-1. doi: 10.1016/j.athoracsur.2009.04.035.
2
Somatic mutations affect key pathways in lung adenocarcinoma.体细胞突变影响肺腺癌的关键通路。
Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.
3
Smoking-related genomic signatures in non-small cell lung cancer.非小细胞肺癌中与吸烟相关的基因组特征。
Am J Respir Crit Care Med. 2008 Dec 1;178(11):1164-72. doi: 10.1164/rccm.200801-142OC. Epub 2008 Sep 5.
4
Smoking affects prognosis after lung cancer surgery.吸烟会影响肺癌手术后的预后。
Surg Today. 2008;38(3):227-31. doi: 10.1007/s00595-007-3599-0. Epub 2008 Feb 29.
5
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer.表皮生长因子受体(EGFR)激酶结构域的“经典”而非“其他”突变与吉非替尼治疗的非小细胞肺癌患者的临床结局相关。
Br J Cancer. 2007 Dec 3;97(11):1560-6. doi: 10.1038/sj.bjc.6604068. Epub 2007 Nov 13.
6
Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer.复发性肺癌患者的表皮生长因子受体基因扩增与吉非替尼敏感性
J Cancer Res Clin Oncol. 2008 May;134(5):569-77. doi: 10.1007/s00432-007-0320-z. Epub 2007 Oct 12.
7
Lung cancer in never smokers--a different disease.从不吸烟者患肺癌——一种不同的疾病。
Nat Rev Cancer. 2007 Oct;7(10):778-90. doi: 10.1038/nrc2190.
8
Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.一项基于人群的1996 - 1998年使用移动低剂量螺旋计算机断层扫描进行肺癌大规模筛查项目的长期随访研究。
Lung Cancer. 2007 Dec;58(3):329-41. doi: 10.1016/j.lungcan.2007.06.022. Epub 2007 Aug 6.
9
National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care.美国非小细胞肺癌全国性调查:流行病学、病理学及治疗模式
Lung Cancer. 2007 Sep;57(3):253-60. doi: 10.1016/j.lungcan.2007.03.012. Epub 2007 Apr 23.
10
The role of gefitinib treatment for Korean never-smokers with advanced or metastatic adenocarcinoma of the lung: a prospective study.吉非替尼治疗韩国非吸烟晚期或转移性肺腺癌患者的作用:一项前瞻性研究。
J Thorac Oncol. 2006 Nov;1(9):965-71.